T

Alpha Teknova, Inc.

TKNO Nasdaq Healthcare · In Vitro & In Vivo Diagnostic Substances Hollister, CA www.teknova.com
$7.81
Mkt Cap 418.3M
Facilities for specific information about our commercial, office, manufacturing, and warehouse space. Ite m 3. Legal Proceedings. We are not a party to any material legal proceedings at this time. Fro…

Facilities for specific information about our commercial, office, manufacturing, and warehouse space. Ite m 3. Legal Proceedings. We are not a party to any material legal proceedings at this time. From time to time, we may become involved in various legal proceedings that arise in the ordinary course of business. For example, we may in the future become involved in legal proceedings relating to customers, employees, suppliers, competitors, government agencies, or others. We will evaluate any claims and lawsuits with respect to their potential merits, our potential defenses and counter claims, and the expected effect on us of defending the claims and a potential adverse result. However, the results of any litigation, investigation, or other legal proceedings are inherently unpredictable and potentially expensive. Any claims against us, whether meritorious or not, could be time-consuming, result in costly litigation, damage our reputation, require significant amounts of management time, and divert significant resources. If any legal proceedings were to be determined adversely to us, or we were to enter into a settlement arrangement, we could be exposed to monetary damages or limits on our ability to operate our business, which could have an adverse effect on our business, financial condition, and operating results. Information pertaining to loss contingencies, 50 including those arising out of potential legal liabilities and related matters, are described in Item 8, "Financial Statements and Supplementary Data - Note 15. Contingencies, and incorporated by reference herein.

/100 Overall
Calculating score…
Running full analysis
📊 Key Metrics
Loading full analysis…
REVENUE TTM
$43.7M
FCF TTM
-$7.4M
Running full 6-factor analysis…